Chengdu Huasun Technology Group Inc., Ltd. (000790.SZ) plans to publicly list and transfer 51% equity of Tibet Kangyu.
Huashen Technology (000790.SZ) announced that the company plans to transfer the controlling stake of its subsidiary Tibet Kangyu Medicine through a public listing.
Chengdu Huasun Technology Group Inc., Ltd. (000790.SZ) announced that it plans to publicly list and transfer the controlling stake of 51% in its subsidiary Tibet Kangyu Pharmaceutical Co., Ltd. (referred to as "Tibet Kangyu") at a listing price of 63.78 million yuan. The equity transfer will be conducted through public listing on the Southwest United Equity Exchange, with the buyer still to be determined.
Related Articles
US Stock Market Move | Quantum concept stocks rise: Quantum Computing (QUBT.US) up nearly 5%
US Stock Market Move | TAL Education Group Sponsored ADR Class A (TAL.US) rose more than 2% as its revenue for the first quarter of the 2026 fiscal year increased by nearly 40% year-on-year.
CMBC CAPITAL (01141) affiliated purchase of bonds in the amount of 10 million US dollars.
US Stock Market Move | Quantum concept stocks rise: Quantum Computing (QUBT.US) up nearly 5%
US Stock Market Move | TAL Education Group Sponsored ADR Class A (TAL.US) rose more than 2% as its revenue for the first quarter of the 2026 fiscal year increased by nearly 40% year-on-year.
CMBC CAPITAL (01141) affiliated purchase of bonds in the amount of 10 million US dollars.
RECOMMEND
EU Defers Two Retaliatory Measures Against U.S. Tariffs by Six Months to Facilitate Trade Negotiations
05/08/2025
July Special Bond Issuance Reaches Year-to-Date Peak, Poised to Reinforce Infrastructure Investment
05/08/2025
Inbound Tourism Accelerates as China’s Travel Service Exports Jump Nearly 70% in H1
05/08/2025
